A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition
about
Selective inhibition of matrix metalloproteinase-9 attenuates secondary damage resulting from severe traumatic brain injurySulfonate-containing thiiranes as selective gelatinase inhibitors.Synthesis, kinetic characterization and metabolism of diastereomeric 2-(1-(4-phenoxyphenylsulfonyl)ethyl)thiiranes as potent gelatinase and MT1-MMP inhibitors.Role of matrix metalloproteinases and therapeutic benefits of their inhibition in spinal cord injury.Matrix metalloproteinase-sensitive thermogelling polymer for bioresponsive local drug delivery.Selective water-soluble gelatinase inhibitor prodrugs.Synthesis and biological evaluation in U87MG glioma cells of (ethynylthiophene)sulfonamido-based hydroxamates as matrix metalloproteinase inhibitorsMatrix metalloproteinase inhibitors as investigative tools in the pathogenesis and management of vascular disease.Structure-Activity Relationship for Thiirane-Based Gelatinase InhibitorsSelective gelatinase inhibitor neuroprotective agents cross the blood-brain barrierMatrix metalloproteinases as potential targets in the venous dilation associated with varicose veins.TM4SF1 Promotes Proliferation, Invasion, and Metastasis in Human Liver Cancer CellsWater-Soluble MMP-9 Inhibitor Reduces Lesion Volume after Severe Traumatic Brain Injury.Matrix Metalloproteinase Inhibitors as Investigational and Therapeutic Tools in Unrestrained Tissue Remodeling and Pathological Disorders.
P2860
Q28534597-FBFBF149-FC8C-4570-ABE2-21A08BC26207Q33598697-83412375-36DD-4FB7-B7FE-6A2FDA8B3FBAQ33983963-F0DD1AD3-6941-418F-9F6D-FE21D1F079A4Q34801330-FEDFD641-7157-4293-9408-4035570BB424Q34858832-3CD30A18-D63B-4E1E-8E52-F58E49831B8EQ35308826-04647B2D-86F1-4AAA-8900-5C0D001E4085Q35871254-E1B7569D-4282-4C73-898B-2E7FF17EFB40Q36009930-B7A99931-4A05-48A4-9089-8D26D519BAEDQ36048569-61EE0771-44CF-444D-B52C-46B2E482252BQ36326852-CA3A4DF0-1D88-4CC0-B92A-5C7F882C6FF2Q36644577-5819B03F-2559-499D-970B-F23B1EE5D9DBQ36939173-09A11C84-B715-422B-8385-CD91E66C9E1CQ38846432-FA119C5C-CF68-4C41-9E34-5C5C0F6B8298Q50916304-5232DFF6-B3AE-429F-8DDA-D2A803F9D801
P2860
A potent gelatinase inhibitor with anti-tumor-invasive activity and its metabolic disposition
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2009
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
A potent gelatinase inhibitor ...... and its metabolic disposition
@en
A potent gelatinase inhibitor ...... and its metabolic disposition.
@nl
type
label
A potent gelatinase inhibitor ...... and its metabolic disposition
@en
A potent gelatinase inhibitor ...... and its metabolic disposition.
@nl
prefLabel
A potent gelatinase inhibitor ...... and its metabolic disposition
@en
A potent gelatinase inhibitor ...... and its metabolic disposition.
@nl
P2093
P2860
P1476
A potent gelatinase inhibitor ...... and its metabolic disposition
@en
P2093
Bill Boggess
Bruce C Noll
Giuseppe Celenza
Jennifer Blase
M Margarida Bernardo
Mark A Suckow
Marta Toth
Mayland Chang
Mijoon Lee
P2860
P304
P356
10.1111/J.1747-0285.2008.00750.X
P50
P577
2009-02-01T00:00:00Z